539 related articles for article (PubMed ID: 1328819)
1. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-term treatment with a new aldose reductase inhibitor, (2S,4S)-6-fluoro-2',5'-dioxospiro-[chroman-4,4'-imidazolidine]-2-carbox amide (SNK-860), on peripheral neuropathy in streptozotocin-induced diabetic rats.
Kato N; Mizuno K; Matsubara A; Nakano K; Kurono M; Yagihashi S
J Diabetes Complications; 1994; 8(1):27-32. PubMed ID: 8167384
[TBL] [Abstract][Full Text] [Related]
3. Effect of a new aldose reductase inhibitor, 8'-chloro-2',3'-dihydrospiro [pyrrolidine-3,6'(5'H)-pyrrolo[1,2,3-de] [1,4]benzoxazine]-2,5,5'- trione (ADN-138), on delayed motor nerve conduction velocity in streptozotocin-diabetic rats.
Hirata Y; Fujimori S; Okada K
Metabolism; 1988 Feb; 37(2):159-63. PubMed ID: 2828821
[TBL] [Abstract][Full Text] [Related]
4. Polyol pathway, 2,3-diphosphoglycerate in erythrocytes and diabetic neuropathy in rats.
Nakamura J; Koh N; Sakakibara F; Hamada Y; Wakao T; Hara T; Mori K; Nakashima E; Naruse K; Hotta N
Eur J Pharmacol; 1995 Dec; 294(1):207-14. PubMed ID: 8788433
[TBL] [Abstract][Full Text] [Related]
5. Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats.
Hotta N; Kakuta H; Fukasawa H; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K
Diabetes Res Clin Pract; 1995 Feb; 27(2):107-17. PubMed ID: 7607048
[TBL] [Abstract][Full Text] [Related]
6. Reduced motor nerve conduction velocity and Na(+)-K(+)-ATPase activity in rats maintained on L-fucose diet. Reversal by myo-inositol supplementation.
Yorek MA; Wiese TJ; Davidson EP; Dunlap JA; Stefani MR; Conner CE; Lattimer SA; Kamijo M; Greene DA; Sima AA
Diabetes; 1993 Oct; 42(10):1401-6. PubMed ID: 8397126
[TBL] [Abstract][Full Text] [Related]
7. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
Gillon KR; Hawthorne JN; Tomlinson DR
Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
[TBL] [Abstract][Full Text] [Related]
8. Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy.
Mizuno K; Kato N; Makino M; Suzuki T; Shindo M
J Diabetes Complications; 1999; 13(3):141-50. PubMed ID: 10509874
[TBL] [Abstract][Full Text] [Related]
9. Adenosine triphosphatase activity in sciatic nerve tissue of streptozocin-induced diabetic rats with and without high dietary sucrose: effect of aldose reductase inhibitors.
Sredy J; Flam BR; Sawicki DR
Proc Soc Exp Biol Med; 1991 Jun; 197(2):135-43. PubMed ID: 1851565
[TBL] [Abstract][Full Text] [Related]
10. A combination of the aldose reductase inhibitor, statil, and the prostaglandin E1 analogue, OP1206.alpha CD, completely improves sciatic motor nerve conduction velocity in streptozocin-induced chronically diabetic rats.
Yasuda H; Sonobe M; Hisanaga T; Kawabata T; Maeda K; Kikkawa R; Shigeta Y
Metabolism; 1992 Jul; 41(7):778-82. PubMed ID: 1320179
[TBL] [Abstract][Full Text] [Related]
11. A sodium-pump defect in diabetic peripheral nerve corrected by sorbinil administration: relationship to myo-inositol metabolism and nerve conduction slowing.
Greene DA
Metabolism; 1986 Apr; 35(4 Suppl 1):60-5. PubMed ID: 2421135
[TBL] [Abstract][Full Text] [Related]
12. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Yorek MA
Int J Exp Diabetes Res; 2002; 3(1):21-36. PubMed ID: 11900277
[TBL] [Abstract][Full Text] [Related]
13. Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity.
Greene DA; Lattimer SA
Diabetes; 1984 Aug; 33(8):712-6. PubMed ID: 6086432
[TBL] [Abstract][Full Text] [Related]
14. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
Tomlinson DR; Moriarty RJ; Mayer JH
Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
[TBL] [Abstract][Full Text] [Related]
15. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition.
Greene DA; Mackway AM
Diabetes; 1986 Oct; 35(10):1106-8. PubMed ID: 3019804
[TBL] [Abstract][Full Text] [Related]
16. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
Mayer JH; Tomlinson DR
Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
[TBL] [Abstract][Full Text] [Related]
17. An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats.
Berti-Mattera L; Day N; Peterson RG; Eichberg J
Metabolism; 1996 Mar; 45(3):320-7. PubMed ID: 8606638
[TBL] [Abstract][Full Text] [Related]
18. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat.
Stevens MJ; Lattimer SA; Kamijo M; Van Huysen C; Sima AA; Greene DA
Diabetologia; 1993 Jul; 36(7):608-14. PubMed ID: 8359577
[TBL] [Abstract][Full Text] [Related]
19. Relation of Na+, K(+)-ATPase to delayed motor nerve conduction velocity: effect of aldose reductase inhibitor, ADN-138, on Na+, K(+)-ATPase activity.
Hirata Y; Okada K
Metabolism; 1990 Jun; 39(6):563-7. PubMed ID: 2161992
[TBL] [Abstract][Full Text] [Related]
20. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism.
Cameron NE; Cotter MA; Dines KC; Maxfield EK; Carey F; Mirrlees DJ
Diabetologia; 1994 Jul; 37(7):651-63. PubMed ID: 7958535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
